相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 2 Study of Dasatinib in the Treatment of Head and Neck Squamous Cell Carcinoma
Heather D. Brooks et al.
CANCER (2011)
Phase 1 Trial of Concurrent Erlotinib, Celecoxib, and Reirradiation for Recurrent Head and Neck Cancer
Johnny Kao et al.
CANCER (2011)
Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer
Banibrata Sen et al.
CLINICAL CANCER RESEARCH (2011)
Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
Hai Xu et al.
CLINICAL CANCER RESEARCH (2011)
The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors
Lokesh Dalasanur Nagaprashantha et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21
Yongci Zhang et al.
INVESTIGATIONAL NEW DRUGS (2011)
Glutathione-Conjugate Transport by RLIP76 Is Required for Clathrin-Dependent Endocytosis and Chemical Carcinogenesis
Sharad S. Singhal et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
Bin Bao et al.
PLOS ONE (2011)
RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
Jyotsana Singhal et al.
PLOS ONE (2011)
Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice
Vladimir N. Anisimov et al.
AGING-US (2010)
Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation
Varisa Pongrakhananon et al.
APOPTOSIS (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer
Udai Banerji et al.
CLINICAL CANCER RESEARCH (2010)
Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer
Nasser Altorki et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
Pawan Kumar et al.
MOLECULAR CANCER (2010)
Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
Susan L. Holbeck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach
Young-Kwang Yoon et al.
MOLECULAR CARCINOGENESIS (2010)
Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice
Maxime Cazorla et al.
PLOS ONE (2010)
RalBP1 Is Necessary for Metastasis of Human Cancer Cell Lines
Zhong Wu et al.
NEOPLASIA (2010)
(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma
Ting Luo et al.
BREAST CANCER RESEARCH (2010)
Biological Effects of a New Vacuolar-H,(+)-ATPase Inhibitor in Colon Carcinoma Cell Lines
Rosanna Supino et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation
Craig D. Simpson et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells
Vivian W. Y. Lui et al.
CARCINOGENESIS (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
Claudio Festuccia et al.
ENDOCRINE-RELATED CANCER (2009)
Personalized cancer diagnostics and therapeutics
Dimitrios H. Roukos
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Role of RLIP76 in doxorubicin resistance in lung cancer (Review)
Rit Vatsyayan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Intestinal Epithelial Cancer Cell Anoikis Resistance: EGFR-Mediated Sustained Activation of Src Overrides Fak-Dependent Signaling to MEK/Erk and/or PI3-K/Akt-1
Marie-Josee Demers et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous Melanoma
Victoria R. Greene et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Active N-Ras and B-Raf Inhibit Anoikis by Downregulating Bim Expression in Melanocytic Cells
Nathaniel B. Goldstein et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Small Molecule Integrin Antagonists in Cancer Therapy
Mayra Paolillo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis
Marjon A. Smit et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway
Kenneth Thress et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Cross talk Initiated by Endothelial Cells Enhances Migration and Inhibits Anoikis of Squamous Cell Carcinoma Cells through STAT3/Akt/ERK Signaling
Kathleen G. Neiva et al.
NEOPLASIA (2009)
SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2
Afshin Dowlati et al.
ANTI-CANCER DRUGS (2008)
Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy
Xuerong Wang et al.
CANCER BIOLOGY & THERAPY (2008)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
Vitaly Balan et al.
CANCER RESEARCH (2008)
Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy
Stuart Thomson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme
David A. Reardon et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
An α5β1 integrin inhibitor attenuates glioma growth
Katrin Faerber et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
αvβ3 integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species
Anamaria Brozovic et al.
MOLECULAR PHARMACOLOGY (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
Getting Started in Biological Pathway Construction and Analysis
Ganesh A. Viswanathan et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
GRP78 and cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth
Gidi Shani et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation
Ana C. E. Campos et al.
NEOPLASIA (2007)
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression
Hui-Wen Lo et al.
CANCER RESEARCH (2007)
The α1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers
T. Mijatovic et al.
JOURNAL OF PATHOLOGY (2007)
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Barbara A. Frederick et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Mevalonate pathway: A review of clinical and therapeutical implications
Irina Buhaescu et al.
CLINICAL BIOCHEMISTRY (2007)
Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin
Pornngarm Limtrakul et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype
Andrea Salmaggi et al.
GLIA (2006)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
Patrick W. B. Derksen et al.
CANCER CELL (2006)
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting
John C. Sok et al.
CLINICAL CANCER RESEARCH (2006)
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer
Eunfung Lee et al.
CANCER RESEARCH (2006)
Glucose regulated proteins in cancer progression, drug resistance and immunotherapy
Yong Fu et al.
CANCER BIOLOGY & THERAPY (2006)
STAT3 as a downstream mediator of Trk signaling and functions
Yu Po Ng ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Anticancer effects of zoledronic acid against human osteosarcoma cells
B. Kubista et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2006)
PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression
SY Lee et al.
LUNG CANCER (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The cardenolide UNBS1450 is able to deactivate nuclear factor κB-mediated cytoprotective effects in human non-small cell lung cancer cells
T Mijatovic et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Stress induction of GRP78/BiP and its role in cancer
JZ Li et al.
CURRENT MOLECULAR MEDICINE (2006)
ER stress, hypoxia tolerance and tumor progression
C Koumenis
CURRENT MOLECULAR MEDICINE (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mechanisms of focal adhesion kinase regulation
LA Cohen et al.
CURRENT CANCER DRUG TARGETS (2005)
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma
D Koul et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations
T Mukohara et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Erlotinib in lung cancer - Molecular and clinical predictors of outcome
MS Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment
DZ Dong et al.
CANCER RESEARCH (2005)
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
LA Edwards et al.
ONCOGENE (2005)
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer
VEPP Lemmens et al.
BRITISH JOURNAL OF SURGERY (2005)
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells
O Berezovskaya et al.
CANCER RESEARCH (2005)
Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells
MS Duxbury et al.
SURGERY (2004)
被撤回的出版物: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
S Douma et al.
NATURE (2004)
Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis
L Wei et al.
ONCOGENE (2004)
Recent insights into the structure and mechanism of the sodium pump
JD Horisberger
PHYSIOLOGY (2004)
Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis
HW Chen et al.
MOLECULAR PHARMACOLOGY (2004)
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex
H Peinado et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
AC Bellail et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer
EA Swan et al.
ORAL ONCOLOGY (2003)
RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival
YC Chien et al.
EMBO REPORTS (2003)
Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis
JR Hsiao et al.
BRITISH JOURNAL OF CANCER (2003)
Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells
GM Oades et al.
JOURNAL OF UROLOGY (2003)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2 - Implication in head and neck squamous cell carcinoma progression
QH Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFκB
QH Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Correlation of Snail expression with histological grade and lymph node status in breast carcinomas
MJ Blanco et al.
ONCOGENE (2002)
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells
A Muscella et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Role of galectin-3 in breast cancer metastasis - Involvement of nitric oxide
YK Song et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Reduction in drug-induced DNA double-strand breaks associated with β1 integrin-mediated adhesion correlates with drug resistance in U937 cells
LA Hazlehurst et al.
BLOOD (2001)
The glucose-regulated proteins: stress induction and clinical applications
AS Lee
TRENDS IN BIOCHEMICAL SCIENCES (2001)
A novel function for the tumor suppressor p16INK4a:: Induction of anoikis via upregulation of the α5β1 fibronectin receptor
T Plath et al.
JOURNAL OF CELL BIOLOGY (2000)
The integrin-linked kinase (ILK) suppresses anoikis
S Attwell et al.
ONCOGENE (2000)
Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition
GCM Zondag et al.
JOURNAL OF CELL BIOLOGY (2000)
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
JR Grandis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Incidence of sentinel node metastasis in patients with thin primary melanoma (≤1 mm) with vertical growth phase
I Bedrosian et al.
ANNALS OF SURGICAL ONCOLOGY (2000)
Matrix survival signaling:: From fibronectin via focal adhesion kinase to c-Jun NH2-terminal kinase
EAC Almeida et al.
JOURNAL OF CELL BIOLOGY (2000)
Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions
PM Fernandez et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
